These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 9658325)

  • 1. Use of balloon-occluded retrograde transvenous obliteration with ethanolamine oleate for the treatment of hepatic encephalopathy in a cirrhotic patient with a large spontaneous splenorenal shunt.
    Numata K; Tanaka K; Kiba T; Saito S; Shirato K; Kitamura T; Sekihara H
    J Gastroenterol; 1998 Jun; 33(3):424-7. PubMed ID: 9658325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intractable hepatic encephalopathy in cirrhotic patients: mid-term efficacy of balloon-occluded retrograde portosystemic shunt obliteration.
    Mukund A; Chalamarla LK; Singla N; Shasthry SM; Sarin SK
    Eur Radiol; 2020 Jun; 30(6):3462-3472. PubMed ID: 32048037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatic encephalopathy due to spontaneous splenorenal shunt: successful treatment by transhepatic shunt embolization.
    Vavasseur D; Duvoux C; Cherqui D; Derhy S; Rahmouni A; Dhumeaux D; Mathieu D
    Cardiovasc Intervent Radiol; 1994; 17(5):298-300. PubMed ID: 7820841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel therapy for non-cirrhotic hyperammonemia due to a spontaneous splenorenal shunt.
    Rogal SS; Hu A; Bandi R; Shaikh O
    World J Gastroenterol; 2014 Jul; 20(25):8288-91. PubMed ID: 25009405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embolization of splenorenal shunt associated to portal vein thrombosis and hepatic encephalopathy.
    Franzoni Lde C; de Carvalho FC; Garzon RG; Yamashiro Fda S; Augusti L; Santos LA; Dorna Mde S; Baima JP; Lima TB; Caramori CA; Silva GF; Romeiro FG
    World J Gastroenterol; 2014 Nov; 20(42):15910-5. PubMed ID: 25400477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
    Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A; Hayashi S; Noguchi M
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience.
    Mukund A; Rajesh S; Arora A; Patidar Y; Jain D; Sarin SK
    J Vasc Interv Radiol; 2012 Sep; 23(9):1200-6. PubMed ID: 22832139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination treatment of transjugular retrograde obliteration and endoscopic embolization for portosystemic encephalopathy with esophageal varices.
    Chikamori F; Kuniyoshi N; Shibuya S; Takase Y
    Hepatogastroenterology; 2004; 51(59):1379-81. PubMed ID: 15362757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H; Toyota N; Hieda M; Ishikawa M; Tanitame K; Tani C; Okazaki A; Takaki S; Aikata H; Chayama K; Awai K
    Hiroshima J Med Sci; 2011 Mar; 60(1):15-9. PubMed ID: 21675043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic varices treated by balloon-occluded retrograde transvenous obliteration in a cirrhotic patient with encephalopathy: a case report.
    Anan A; Irie M; Watanabe H; Sohda T; Iwata K; Suzuki N; Yoshikane M; Nakane H; Hashiba T; Yokoyama M; Higashihara H; Okazaki M; Sakisaka S
    Gastrointest Endosc; 2006 May; 63(6):880-4. PubMed ID: 16650568
    [No Abstract]   [Full Text] [Related]  

  • 12. Portosystemic encephalopathy treated with balloon-occluded retrograde transvenous obliteration.
    Kawanaka H; Ohta M; Hashizume M; Tomikawa M; Higashi H; Kishihara F; Sugimachi K; Tokumatsu M
    Am J Gastroenterol; 1995 Mar; 90(3):508-10. PubMed ID: 7872302
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-cirrhotic portal-systemic encephalopathy caused by enlargement of a splenorenal shunt after pancreaticoduodenectomy for locally advanced duodenal cancer: report of a case.
    Kasagi Y; Saeki H; Akahoshi T; Kawasaki J; Ando K; Oki E; Ohga T; Tomikawa M; Kakeji Y; Shirabe K; Maehara Y
    Surg Today; 2014 Aug; 44(8):1573-6. PubMed ID: 23982193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals.
    Koito K; Namieno T; Nagakawa T; Morita K
    AJR Am J Roentgenol; 1996 Nov; 167(5):1317-20. PubMed ID: 8911204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
    J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent development of balloon-occluded retrograde transvenous obliteration.
    Kobayakawa M; Ohnishi S; Suzuki H
    J Gastroenterol Hepatol; 2019 Mar; 34(3):495-500. PubMed ID: 30170340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon-occluded retrograde transvenous obliteration of a gastric varix via the left inferior phrenic vein.
    Matsumoto T; Yamagami T; Nakamura N; Kato T; Hirota T; Yoshimatsu R; Nishimura T
    Br J Radiol; 2008 Oct; 81(970):e246-8. PubMed ID: 18796552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal-systemic Encephalopathy due to Complicated Spleno-renal Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration Using a Double Coaxial Balloon Catheter System and Shape-memory Coils.
    Matsuoka S; Yamana Y; Ishii T; Kumagawa M; Mizutani T; Kamimura S; Matsumoto N; Nakamura H; Nirei K; Tatsuo K; Moriyama M
    Intern Med; 2018 Jul; 57(13):1861-1866. PubMed ID: 29491295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.